Lundy Meghan G, Forman Andrea, Valverde Kathleen, Kessler Lisa
Genetic Counseling Program, Arcadia University, 450 S Easton Rd, Glenside, PA, 19038, USA,
J Genet Couns. 2014 Aug;23(4):618-32. doi: 10.1007/s10897-014-9692-9. Epub 2014 Feb 27.
Genetic testing recommendations for hereditary breast and ovarian cancer involve pedigree analysis and consultation of testing guidelines. The testing landscape for hereditary cancer syndromes is shifting as multiplex panel tests become more widely integrated into clinical practice. The purpose of the current study was to assess how genetic counselors utilize pedigrees to make recommendations for genetic testing, to determine consistency of these recommendations with National Comprehensive Cancer Network (NCCN) Guidelines and to explore current use of multiplex panel testing. Sixty-nine genetic counselors were recruited through the National Society of Genetic Counselors Cancer Special Interest Group's Discussion Forum. Participation involved pedigree analysis and completion of an online questionnaire assessing testing recommendations and use of multiplex panel testing. Pedigree analysis and test recommendations were scored for consistency with NCCN guidelines. The average score was 12.83/15 indicating strong consistency with NCCN guidelines. Participants were more likely to consider multiplex testing when pedigrees demonstrated highly penetrant dominant inheritance but were not indicative of a particular syndrome. Participant concerns about multiplex panel testing include limited guidelines for both testing eligibility and medical management. This study demonstrates high utilization of pedigree analysis and raises new questions about its use in multiplex genetic testing.
遗传性乳腺癌和卵巢癌的基因检测建议涉及系谱分析和检测指南的咨询。随着多重基因检测面板更广泛地融入临床实践,遗传性癌症综合征的检测格局正在发生变化。本研究的目的是评估遗传咨询师如何利用系谱为基因检测提供建议,确定这些建议与美国国立综合癌症网络(NCCN)指南的一致性,并探索多重基因检测面板的当前使用情况。通过国家遗传咨询师协会癌症特别兴趣小组的讨论论坛招募了69名遗传咨询师。参与包括系谱分析和完成一份评估检测建议和多重基因检测面板使用情况的在线问卷。对系谱分析和检测建议与NCCN指南的一致性进行评分。平均得分为12.83/15,表明与NCCN指南高度一致。当系谱显示高度显性遗传但不指示特定综合征时,参与者更有可能考虑进行多重检测。参与者对多重基因检测面板的担忧包括检测资格和医疗管理的指南有限。本研究表明系谱分析的利用率很高,并对其在多重基因检测中的应用提出了新问题。